Clinical Trial: Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Microtia
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2, Multi-Center, Open-Label, Single-Arm Safety, Tolerability, and Efficacy Study of an Auricle and Wedge Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral M
Brief Summary:
AUR-201 is indicated for the treatment of Grade II, III, or IV unilateral microtia in patients 8 to 29 years of age.
Read more